Mann Paul Elliot

Insider Reports History

Reporting-owner location: Boca Raton, FL
Latest reporting-owner signature: /s/ Donald Ainscow, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mann Paul Elliot

Form 4 holding Chairman and CEO, Director

ASP Isotopes Inc.

Security class: Common Stock
Shares / value: 9,579,845
Estimated value: $74,339,597
Report date: 03 Jun 2026
Price: $7.76
Ownership: Direct

Form 4 holding Director

ABEONA THERAPEUTICS INC.

Security class: Common Stock
Shares / value: 16,907
Estimated value: $86,395
Report date: 26 Sep 2022
Price: $5.11
Ownership: Direct

Form 4 holding Director

Healthtech Solutions, Inc./UT

Security class: Common Stock
Shares / value: 2,666,667
Estimated value
Report date: 22 Nov 2022
Price
Ownership: Direct

Form 4 holding Chairman and CEO, Director

ASP Isotopes Inc.

Security class: Employee Stock Option (right to buy)
Shares / value: 0
Estimated value
Report date: 09 Sep 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Mann Paul Elliot

4 ASPI

ASP Isotopes Inc.

Report period: 28 May 2026
Transactions: 4
Transaction value: -$2,004,337
Accepted by SEC: 03 Jun 2026, 21:45
Role: Chairman and CEO, Director
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 02 Mar 2026
Transactions: 1
Transaction value: +$881,464
Accepted by SEC: 02 Mar 2026, 21:50
Role: Executive Chairman
Next action: Open filing details

3

Illumination Acquisition Corp. I

Report period: 26 Feb 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 26 Feb 2026, 17:24
Role: Director
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 01 Dec 2025
Transactions: 1
Transaction value: -$932,866
Accepted by SEC: 03 Dec 2025, 21:42
Role: Executive Chairman, Director
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 17 Nov 2025
Transactions: 2
Transaction value: -$1,132,988
Accepted by SEC: 28 Nov 2025, 21:41
Role: Executive Officer, Director
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 08 Sep 2025
Transactions: 8
Transaction value: -$1,371,519
Accepted by SEC: 10 Sep 2025, 21:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 15 Apr 2025
Transactions: 3
Transaction value: -$5,326,397
Accepted by SEC: 17 Apr 2025, 19:57
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 14 Apr 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Apr 2025, 08:42
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 06 Sep 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Sep 2024, 18:37
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 15 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Jul 2024, 10:33
Role: Chief Executive Officer
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 01 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Mar 2023, 15:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 30 Dec 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Feb 2023, 11:14
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ASPI

ASP Isotopes Inc.

Report period: 15 Nov 2022
Transactions: 2
Transaction value: +$150,000
Accepted by SEC: 15 Nov 2022, 07:19
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

3 ASPI

ASP Isotopes Inc.

Report period: 09 Nov 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 14 Nov 2022, 15:36
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 ABEO

ABEONA THERAPEUTICS INC.

Report period: 26 Sep 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Sep 2022, 16:34
Role: Director
Next action: Open filing details

4/A

Healthtech Solutions, Inc./UT

Report period: 10 Nov 2021
Transactions: 3
Transaction value: $0
Accepted by SEC: 30 Nov 2022, 20:47
Role: Director
Next action: Open filing details

4

Healthtech Solutions, Inc./UT

Report period: 10 Nov 2021
Transactions: 3
Transaction value: $0
Accepted by SEC: 30 Nov 2022, 20:31
Role: Director
Next action: Open filing details

3

Healthtech Solutions, Inc./UT

Report period: 13 Jul 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 16 Jul 2021, 17:49
Role: Director
Next action: Open filing details

4 ABEO

ABEONA THERAPEUTICS INC.

Report period: 25 May 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 27 May 2021, 21:49
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .